California-based medtech group RefleXion Medical touted an $11.6 million Series A fundraising round, hoping to use the new funds to expand research & development efforts for its guided radiation therapy technology.
Oncology
Veran nears $5M fundraising goal for airway imaging
Missouri-based Veran Medical Technologies is on the verge of closing a $5 million funding round in support of its electromagnetic airway mapping system, regulatory filings show.
Varian to acquire cancer software maker Velocity Medical
Varian Medical (NYSE:VAR) said it inked a deal to acquire Velocity Medical Solutions’ cancer clinic software.
OnTarget Labs lands $15M for tumor fluorescing tech
OnTarget Laboratories said it landed a $15 million investment from a pair of backers for its tumor-lighting technology developed at Purdue University by the founder of Endocyte (NSDQ:ECYT).
Lumicell adds another $600,000 in funding
Imaging systems maker Lumicell Diagnostics amended a previously closed $1 million funding round after landing another $560,000 in financing from 2 new investors, regulatory filings show.
Partnership aims to turn the tables on childhood cancer in the Middle East
By Lisa Fratt
Geography can be cruel. An 8-year-old diagnosed with leukemia in Europe or North America can expect a challenging but curable course. Her care, provided by a team of pediatric specialists, includes state-of-the-art imaging, thorough infection prevention and, often, multiple options for treatment.
A 6-minute breathalyzer for breast cancer | MassDevice.com On Call
MASSDEVICE ON CALL — Diagnostics maker Menssana Research is making promising progress with a breath-test that the company says can identify at-risk breast cancer cases in just 6 minutes.
In a study of nearly 250 women at 3 centers in New Jersey, Washington and the Netherlands the test was able to accurately identify women with early stage breast cancer or with abnormal mammogram, Menssana said.
Update: Seno Medical closing in on funding goal, now at $35M
Seno Medical is inching to its $39 million fundraising objective, having brought in $34.6 million in its Series C equity funding round.
San Antonio-based Seno has been at this for some time, and for this round has brought in MedCare Investment Funds as a lead investor. The funding is going towards the company’s U.S. pivotal study of the Imagio breast imaging device, as well as chasing CE Mark approval in Europe.
AMIC looks to down-classify brachytherapy’s FDA status
Washington-based Advanced Medical Isotope Corp. is evaluating its options for U.S. market approval of its proprietary brachytherapy cancer product, the company announced.
Medicare takes another look at low-dose CT scanning for lung cancer
Medicare regulators agreed this month to review their coverage decisions for low-dose computed tomography scanning in patients with lung cancer, after being petitioned by leaders from a pair of national healthcare groups.